4//SEC Filing
LINK WILLIAM J PHD 4
Accession 0001228684-25-000005
CIK 0001819790other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:07 PM ET
Size
13.6 KB
Accession
0001228684-25-000005
Insider Transaction Report
Form 4
LINK WILLIAM J PHD
Director
Transactions
- Sale
Common Stock
2025-12-15$80.80/sh−5,046$407,717→ 136,286 total - Sale
Common Stock
2025-12-15$81.75/sh−6,306$515,516→ 129,980 total - Sale
Common Stock
2025-12-15$82.39/sh−1,148$94,584→ 128,832 total - Sale
Common Stock
2025-12-15$80.71/sh−5,680$458,433→ 4,766 total(indirect: By Link Family Enterprise, LP) - Sale
Common Stock
2025-12-15$81.50/sh−4,766$388,429→ 0 total(indirect: By Link Family Enterprise, LP)
Footnotes (8)
- [F1]The sales were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025.
- [F2]The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $80.21 to $81.20. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $81.21 to $82.19. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $82.23 to $82.92. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The sales were not effected by a sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F6]The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $80.21 to $81.20. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The Reporting Person may be deemed to beneficially own the shares indirectly by reason of the Reporting Person as the controlling member of Link Family Enterprise, LP.
- [F8]The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $81.21 to $81.79. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001228684
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 4:07 PM ET
- Size
- 13.6 KB